Cargando…
Potency of botulinum toxin drugs: test systems and labelling
Cell-based assays are a novel method to determine potency of botulinum toxin drugs. Manufacturers are working on their acquisition, development and implementation to reduce animal consumption during the manufacturing process. Potency labelling of botulinum toxin drugs differes principally between Ip...
Autores principales: | Dressler, Dirk, Johnson, Eric A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468031/ https://www.ncbi.nlm.nih.gov/pubmed/36040625 http://dx.doi.org/10.1007/s00702-022-02535-z |
Ejemplares similares
-
Botulinum toxin therapy: past, present and future developments
por: Dressler, Dirk, et al.
Publicado: (2022) -
Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013) -
Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020) -
Botulinum toxin dosing in arm muscles: contextual factors
por: Dressler, Dirk, et al.
Publicado: (2021) -
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort
por: Dressler, Dirk, et al.
Publicado: (2020)